Jie Liang
Second Affiliated Hospital of Zhejiang University(CN)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Liver Disease Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates(2016)203 cited
- → Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics(2023)119 cited
- → Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease(2023)110 cited
- → Resveratrol Ameliorates Mitochondrial Elongation via Drp1/Parkin/PINK1 Signaling in Senescent‐Like Cardiomyocytes(2017)102 cited
- → Roles of PI3K/Akt and c-Jun Signaling Pathways in Human Papillomavirus Type 16 Oncoprotein-Induced HIF-1α, VEGF, and IL-8 Expression and In Vitro Angiogenesis in Non-Small Cell Lung Cancer Cells(2014)95 cited
- → Sulforaphane Inhibits Inflammatory Responses of Primary Human T-Cells by Increasing ROS and Depleting Glutathione(2018)76 cited
- → Sulforaphane as anticancer agent: A double-edged sword? Tricky balance between effects on tumor cells and immune cells(2018)75 cited
- → MicroRNA-29 is an essential regulator of brain maturation through regulation of CH methylation(2021)71 cited
- → Th17 cells regulate the production of CXCL1 in breast cancer(2018)70 cited
- → A rapid and efficient method for primary culture of human adipose-derived stem cells(2013)60 cited